Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is luteinizing hormone needed for optimal ovulation induction?

Juan Balasch1, Francisco Fábregues

  • 1Clinical Institute of Gynecology, Obstetrics and Neonatology, Faculty of Medicine, University of Barcelona, Hospital Clínic-Institut d'Investigacions Biomèdiques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. jbalasch@medicina.ub.es

Current Opinion in Obstetrics & Gynecology
|May 29, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disentangling the current role of LH activity in assisted reproduction: from biology to patient personalization.

Reproductive biomedicine online·2025
Same author

Exploring Oxidative Stress in Different Endometriosis Phenoptypes: Insights from Ovarian and Systemic Perspectives by the Study of SIRT3.

International journal of molecular sciences·2025
Same author

The role of sperm DNA fragmentation in reproduction: a SWOT analysis.

Journal of assisted reproduction and genetics·2025
Same author

Unusual ovarian hyperstimulation syndrome presentation: Pleural effusion without ascites. A case report.

World journal of clinical cases·2025
Same author

Endometrial receptivity tests in reproduction: a SWOT analysis.

AJOG global reports·2023
Same author

The role of thrombophilias in reproduction: A swot analysis.

European journal of obstetrics, gynecology, and reproductive biology·2022

Luteinizing hormone (LH) is essential for natural cycles, but its need in ovulation induction is debated. This review examines if all patients require LH for follicular growth and explores new treatments with recombinant human LH.

Area of Science:

  • Reproductive Endocrinology
  • Human Reproduction
  • Folliculogenesis

Background:

  • The essential role of luteinizing hormone (LH) in the natural menstrual cycle is well-established.
  • Controversy exists regarding the necessity of exogenous LH for ovulation induction.
  • Recent advancements in understanding folliculogenesis coincide with the introduction of recombinant gonadotropins.

Purpose of the Study:

  • To critically analyze the requirement of LH for follicular growth stimulation in all patient populations.
  • To evaluate the utility of recombinant human LH in treating ovulatory disorders.
  • To explore novel therapeutic opportunities for assisted reproduction utilizing recombinant human LH.

Main Methods:

  • Review of current literature on the role of LH in human folliculogenesis.

Related Experiment Videos

  • Analysis of clinical data regarding ovulation induction with and without exogenous LH.
  • Assessment of the impact of recombinant gonadotropins on assisted reproductive technologies.

    • Main Results:

    • Evidence suggests LH is not universally required for follicular development in all patients undergoing stimulation.
    • Recombinant human LH offers potential benefits for specific patient groups with ovulatory dysfunction.
    • The availability of recombinant LH expands treatment options for individuals undergoing assisted reproduction.

    Conclusions:

    • The necessity of LH supplementation for follicular growth stimulation requires individualized patient assessment.
    • Recombinant human LH presents a valuable therapeutic option for enhancing fertility treatments.
    • Further research is warranted to optimize the use of recombinant LH in diverse reproductive contexts.